GnRH glycs PPD vaccine - Protherics

Drug Profile

GnRH glycs PPD vaccine - Protherics

Alternative Names: GnRH glycs PPD

Latest Information Update: 16 Jul 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Protherics
  • Class Hormones; Vaccines
  • Mechanism of Action Gonadotropin releasing hormone inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 16 Jul 2002 Discontinued - Preclinical for Breast cancer in United Kingdom (Intraperitoneal)
  • 21 Oct 1999 Proteus International has merged with Therapeutic Antibodies to form Protherics
  • 16 Oct 1997 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top